AirSculpt Technologies (AIRS) Competitors $7.00 +0.22 (+3.24%) (As of 11/22/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends AIRS vs. ARA, JYNT, WW, HNGR, TRNS, VRDN, AHCO, CDNA, AVAH, and PNTGShould you be buying AirSculpt Technologies stock or one of its competitors? The main competitors of AirSculpt Technologies include American Renal Associates (ARA), Joint (JYNT), WW International (WW), Hanger (HNGR), Transcat (TRNS), Viridian Therapeutics (VRDN), AdaptHealth (AHCO), CareDx (CDNA), Aveanna Healthcare (AVAH), and The Pennant Group (PNTG). AirSculpt Technologies vs. American Renal Associates Joint WW International Hanger Transcat Viridian Therapeutics AdaptHealth CareDx Aveanna Healthcare The Pennant Group American Renal Associates (NYSE:ARA) and AirSculpt Technologies (NASDAQ:AIRS) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their dividends, risk, valuation, earnings, community ranking, institutional ownership, analyst recommendations, profitability and media sentiment. Which has preferable valuation and earnings, ARA or AIRS? AirSculpt Technologies has lower revenue, but higher earnings than American Renal Associates. AirSculpt Technologies is trading at a lower price-to-earnings ratio than American Renal Associates, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAmerican Renal Associates$822.52M0.48-$13.79M$0.2644.31AirSculpt Technologies$195.92M2.07-$4.48M-$0.14-50.00 Do analysts recommend ARA or AIRS? AirSculpt Technologies has a consensus target price of $5.00, indicating a potential downside of 28.57%. Given AirSculpt Technologies' stronger consensus rating and higher possible upside, analysts plainly believe AirSculpt Technologies is more favorable than American Renal Associates.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score American Renal Associates 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00AirSculpt Technologies 0 Sell rating(s) 4 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Does the media refer more to ARA or AIRS? In the previous week, AirSculpt Technologies had 5 more articles in the media than American Renal Associates. MarketBeat recorded 5 mentions for AirSculpt Technologies and 0 mentions for American Renal Associates. AirSculpt Technologies' average media sentiment score of 0.28 beat American Renal Associates' score of 0.00 indicating that AirSculpt Technologies is being referred to more favorably in the news media. Company Overall Sentiment American Renal Associates Neutral AirSculpt Technologies Neutral Is ARA or AIRS more profitable? American Renal Associates has a net margin of -2.04% compared to AirSculpt Technologies' net margin of -4.13%. AirSculpt Technologies' return on equity of 2.22% beat American Renal Associates' return on equity.Company Net Margins Return on Equity Return on Assets American Renal Associates-2.04% -3.56% -0.24% AirSculpt Technologies -4.13%2.22%0.90% Do institutionals and insiders hold more shares of ARA or AIRS? 78.4% of American Renal Associates shares are held by institutional investors. Comparatively, 91.5% of AirSculpt Technologies shares are held by institutional investors. 9.5% of American Renal Associates shares are held by company insiders. Comparatively, 78.8% of AirSculpt Technologies shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term. Which has more risk & volatility, ARA or AIRS? American Renal Associates has a beta of 1.11, indicating that its stock price is 11% more volatile than the S&P 500. Comparatively, AirSculpt Technologies has a beta of 1.57, indicating that its stock price is 57% more volatile than the S&P 500. Does the MarketBeat Community favor ARA or AIRS? American Renal Associates received 196 more outperform votes than AirSculpt Technologies when rated by MarketBeat users. Likewise, 62.73% of users gave American Renal Associates an outperform vote while only 39.29% of users gave AirSculpt Technologies an outperform vote. CompanyUnderperformOutperformAmerican Renal AssociatesOutperform Votes20762.73% Underperform Votes12337.27% AirSculpt TechnologiesOutperform Votes1139.29% Underperform Votes1760.71% SummaryAirSculpt Technologies beats American Renal Associates on 11 of the 17 factors compared between the two stocks. Ad Insiders Exposed917 Trades… Zero Losses?As you likely know, the “Trump bump” launched stocks to record highs after he secured his second reelection bid. Now, Trump and his team are coming to gut government regulation – and it’s going to create some incredible market opportunities. But while the masses chase large-cap tech and so-called AI stocks, a small circle of traders are using a strange but tactical method to find a pool of “hidden Trump trades.”Go here to see how you can start accessing these opportunities today Get AirSculpt Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for AIRS and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart AIRS vs. The Competition Export to ExcelMetricAirSculpt TechnologiesOffices & clinics of medical doctors IndustryBusiness SectorNASDAQ ExchangeMarket Cap$405.16M$1.03B$6.90B$8.84BDividend YieldN/AN/A2.92%4.09%P/E Ratio-50.0010.8845.8117.69Price / Sales2.071.50539.28162.66Price / Cash30.1143.0426.5336.29Price / Book4.903.335.096.50Net Income-$4.48M-$52.07M$123.61M$226.03M7 Day Performance7.53%2.51%6.63%3.96%1 Month Performance21.32%-4.13%13.78%3.77%1 Year Performance28.91%-4.28%34.34%29.32% AirSculpt Technologies Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)AIRSAirSculpt Technologies0.5752 of 5 stars$7.00+3.2%$5.00-28.6%+28.9%$405.16M$195.92M-50.00346ARAAmerican Renal AssociatesN/A$11.52flatN/A+0.0%$397.94M$822.52M44.314,977JYNTJoint3.8795 of 5 stars$11.57+1.9%$17.50+51.3%+27.0%$170.07M$120.80M-10.15444WWWW International2.4178 of 5 stars$1.01+6.3%$4.50+345.5%-84.8%$70.28M$889.55M0.004,850HNGRHangerN/A$18.72flatN/AN/A$732.38M$1.12B19.715,200TRNSTranscat2.9469 of 5 stars$106.79+3.9%$127.25+19.2%+11.5%$945.96M$270.61M53.931,104VRDNViridian Therapeutics2.5338 of 5 stars$19.62-0.9%$36.33+85.2%+28.8%$1.55B$310,000.00-4.5550Analyst RevisionAHCOAdaptHealth3.0323 of 5 stars$9.89+1.7%$11.67+18.0%+15.9%$1.33B$3.20B-5.9910,700Analyst ForecastCDNACareDx3.7951 of 5 stars$22.52+0.7%$29.60+31.4%+135.3%$1.20B$312.78M-8.34740AVAHAveanna Healthcare0.4915 of 5 stars$5.80+0.5%$4.27-26.4%+153.9%$1.12B$1.90B-17.0633,500PNTGThe Pennant Group3.6624 of 5 stars$30.50-0.9%$38.25+25.4%+126.5%$1.05B$544.89M44.855,791Positive News Related Companies and Tools Related Companies ARA Alternatives JYNT Alternatives WW Alternatives HNGR Alternatives TRNS Alternatives VRDN Alternatives AHCO Alternatives CDNA Alternatives AVAH Alternatives PNTG Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:AIRS) was last updated on 11/23/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredBut another coin could soar even higher …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin co...Weiss Ratings | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AirSculpt Technologies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share AirSculpt Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free AIRS Stock Alerts